Literature DB >> 6768142

Supermelanotic hybrids derived from mouse melanomas and normal mouse cells.

R Halaban, J Nordlund, U Francke, G Moellmann, J M Eisenstadt.   

Abstract

Hybrids formed between HPRT- Cloudman mouse melanoma and normal cells were isolated. The parental origin of the hybrids was verified by isoenzyme and karyotype analyses. These hybrid cells differed in two major characteristics from hybrids of melanoma and established fibroblastic cells. (1) They grew as tumors when injected into mice, and (2) they expressed differentiated melanocytic functions. At least one of the differentiated functions was overexpressed. The specific activity of tyrosinase was 3-20 times higher in the hybrid cells than in the parental mouse melanoma. The overexpression of tyrosinase in these hybrid cells has been stable for more than a year, has been transmitted to subclones of the original hybrid cell lines, and has been expressed in tumors that grew after injections of hybrid cells into animals.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6768142     DOI: 10.1007/bf01538694

Source DB:  PubMed          Journal:  Somatic Cell Genet        ISSN: 0098-0366


  9 in total

Review 1.  Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants.

Authors:  L Larizza; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

2.  Melanoma x macrophage hybrids with enhanced metastatic potential.

Authors:  M Rachkovsky; S Sodi; A Chakraborty; Y Avissar; J Bolognia; J M McNiff; J Platt; D Bermudes; J Pawelek
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

Review 3.  Viewing malignant melanoma cells as macrophage-tumor hybrids.

Authors:  John M Pawelek
Journal:  Cell Adh Migr       Date:  2007-01-15       Impact factor: 3.405

4.  Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor.

Authors:  R S Kerbel; A E Lagarde; J W Dennis; T P Donaghue
Journal:  Mol Cell Biol       Date:  1983-04       Impact factor: 4.272

5.  Suppression of malignancy in human cancer cells: issues and challenges.

Authors:  A B Sabin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

6.  Suppression of properties associated with malignancy in murine melanoma-melanocyte hybrid cells.

Authors:  W F Wakeling; J Greetham; L M Devlin; D C Bennett
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

7.  Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival.

Authors:  Charles E Gast; Alain D Silk; Luai Zarour; Lara Riegler; Joshua G Burkhart; Kyle T Gustafson; Michael S Parappilly; Minna Roh-Johnson; James R Goodman; Brennan Olson; Mark Schmidt; John R Swain; Paige S Davies; Vidya Shasthri; Shinji Iizuka; Patrick Flynn; Spencer Watson; James Korkola; Sara A Courtneidge; Jared M Fischer; Jerry Jaboin; Kevin G Billingsley; Charles D Lopez; Julja Burchard; Joe Gray; Lisa M Coussens; Brett C Sheppard; Melissa H Wong
Journal:  Sci Adv       Date:  2018-09-12       Impact factor: 14.136

8.  Regulation of tyrosinase in human melanocytes grown in culture.

Authors:  R Halaban; S H Pomerantz; S Marshall; D T Lambert; A B Lerner
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

9.  Spontaneous fusion of malignant and host mouse cells in culture detected by phosphoglucose isomerase (GPI) isoenzymes.

Authors:  M J Marshall; D G Shone; J M Windle; M Worsfold
Journal:  Br J Cancer       Date:  1982-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.